Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014495
Status:
COMPLETED
Last Update Posted:
2016-01-22
First Post:
2001-04-10
Brief Title:
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| childhood myelodysplastic syndromes | View |
| recurrent childhood acute myeloid leukemia | View |
| recurrent adult acute myeloid leukemia | View |
| accelerated phase chronic myelogenous leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| untreated adult acute myeloid leukemia | View |
| untreated childhood acute myeloid leukemia and other myeloid malignancies | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| chronic myelomonocytic leukemia | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| childhood chronic myelogenous leukemia | View |
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with t1517q22q12 | View |